Role of CB2 in the Immune System Explained
Discover the critical role of CB2 receptors in the immune system, their interaction with cannabis compounds, and how they contribute to overall health.
CB1 receptors in the brain are the main target of THC. They sit on the surface of nerve cells, respond to endocannabinoids the body makes on its own, and change how much neurotransmitter a neuron releases. That signal shapes memory, mood, appetite, pain, and movement.
CB1 is a protein built from the CNR1 gene. It belongs to the G protein-coupled receptor family, the same broad class that handles adrenaline, dopamine, and serotonin signals.
cb2 receptors and inflammation
Inside the brain, CB1 receptors work as brakes. They couple to Gi/o proteins, which lower cyclic AMP, open potassium channels, and close calcium channels. The result is a quieter presynaptic terminal and less neurotransmitter released into the gap.
cb1 and cb2 receptors explained
CB1 shows up in high numbers in the cortex, hippocampus, basal ganglia, cerebellum, amygdala, and hypothalamus. Each of those areas maps to a known cannabis effect.
cb1 and cb2 receptors explained
The brainstem holds few CB1 receptors. That matters because the brainstem controls breathing, and it is one reason cannabis does not stop respiration the way opioids can.
CB1 signaling runs backward compared with most synapses. A postsynaptic neuron makes endocannabinoids on demand, releases them, and they travel back to CB1 receptors on the presynaptic side.
This on-demand design keeps the system local and short-lived. Endocannabinoids are not stored in vesicles the way dopamine or serotonin are.
THC is a partial agonist at CB1. It binds the same pocket as anandamide and 2-AG, but with higher affinity, and it stays longer.
That difference explains the high. Instead of a short, local brake signal, THC switches on CB1 receptors across the brain at once and keeps them active for hours.
Most intoxicating effects come from CB1. Animals without working CB1 receptors do not show THC reward or THC-induced memory problems.
CBD has low affinity for CB1 and does not turn the receptor on. It acts as a negative allosteric modulator, meaning it binds a different site and weakens how THC and endocannabinoids activate CB1.
CBD also blocks FAAH, the enzyme that clears anandamide. Slower breakdown can raise anandamide levels, which may explain part of CBD's calming effects.
That is why CBD on its own does not produce a high, and why taking it with THC can shift the experience.
CB1 and CB2 are both cannabinoid receptors, but they live in different places and do different jobs.
CB2 also shows up in some neurons and in the gut, so the split is not absolute.
Repeated THC exposure pushes CB1 receptors to adapt. Cells pull receptors inside, build fewer of them, and blunt the response to future signals.
These changes reverse with abstinence. Most reports put the timeline at about two to four weeks, though the pace varies by person and by how much was used.
Drug developers learned the hard way that blocking CB1 has costs. Rimonabant, a CB1 inverse agonist sold in Europe for weight loss, was pulled from the market in 2008 after reports of depression, anxiety, and suicidal thoughts.
They play a big part. CB1 receptors in the hypothalamus and brainstem help set hunger and satiety signals. THC triggers the same receptors, which is why cannabis users often get hungry.
THC itself is intoxicating, so no. Researchers are testing selective compounds that hit some CB1 pathways and not others, but nothing like that is on the legal market.
They rank among the most abundant G protein-coupled receptors in the brain, with the highest density in the cortex, hippocampus, and cerebellum. Exact counts vary by method and by region.
Not in a simple way. CBD acts as a negative allosteric modulator at CB1, so it dampens receptor activity rather than shutting it off.
None of this is medical advice. If you use cannabis, know that CB1 is the receptor doing most of the work.